|
Name |
Accession |
Description |
Interval |
E-value |
| LCB5 |
COG1597 |
Phosphatidylglycerol kinase, diacylglycerol kinase family [Lipid transport and metabolism, ... |
1-297 |
1.46e-99 |
|
Phosphatidylglycerol kinase, diacylglycerol kinase family [Lipid transport and metabolism, General function prediction only];
Pssm-ID: 441205 [Multi-domain] Cd Length: 295 Bit Score: 294.07 E-value: 1.46e-99
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 498399969 1 MKKAVLIVNPSSGGEKAKEFETLAEEKLKQLFDEVVVKQTEKGGDAEQFAREAAESHFDSVFVMGGDGTVNEGISGLAEQ 80
Cdd:COG1597 2 MMRALLIVNPASGRGRAARLLERLVAALRAAGLEVEVLETESPGDATELAREAAAEGADLVVAAGGDGTVNEVANGLAGT 81
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 498399969 81 ayRPKFGFFPLGTVNDLARALNLPMDPEEAIQQLDLEKTSALDVGKINDDYFMNVVAIGTIPESINDVDVEQKTKLGKLA 160
Cdd:COG1597 82 --GPPLGILPLGTGNDFARALGIPLDPEAALEALLTGRTRRIDLGRVNGRYFLNVAGIGFDAEVVERANRALKRRLGKLA 159
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 498399969 161 YFISGAKHLANAQTYPFHLSLDQKEQTIESSTVLVGLTNSIGGFETLLPEAQVDDGKLHLVYLKDQSLWDAVKAVPDLLK 240
Cdd:COG1597 160 YVLAALRALLRYRPFRLRIELDGEEIEGEALLVAVGNGPYYGGGLRLAPDASLDDGLLDVVVVRPLSRLRLLRLLPRLLR 239
|
250 260 270 280 290
....*....|....*....|....*....|....*....|....*....|....*...
gi 498399969 241 GVDQSTDNLVYLTFKEgtISLENQEELTTNVDGDE-GAALPITLEILPKHLTVYCGEE 297
Cdd:COG1597 240 GRHLRHPGVRYFRARE--VEIESDRPLPVQLDGEPlGLATPLEFEVLPGALRVLVPAD 295
|
|
| PRK13337 |
PRK13337 |
putative lipid kinase; Reviewed |
1-298 |
6.16e-69 |
|
putative lipid kinase; Reviewed
Pssm-ID: 183982 [Multi-domain] Cd Length: 304 Bit Score: 216.45 E-value: 6.16e-69
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 498399969 1 MKKAVLIVNPSSGGEKAKEfeTLAE--EKLKQLFDEVVVKQTEKGGDAEQFAREAAESHFDSVFVMGGDGTVNEGISGLA 78
Cdd:PRK13337 1 MKRARIIYNPTSGRELFKK--NLPDvlQKLEQAGYETSAHATTGPGDATLAAERAVERKFDLVIAAGGDGTLNEVVNGIA 78
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 498399969 79 EQAYRPKFGFFPLGTVNDLARALNLPMDPEEAIQQLDLEKTSALDVGKINDDYFMNVVAIGTIPESINDVDVEQKTKLGK 158
Cdd:PRK13337 79 EKENRPKLGIIPVGTTNDFARALHVPRDIEKAADVIIEGHTVPVDIGKANNRYFINIAGGGRLTELTYEVPSKLKTMLGQ 158
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 498399969 159 LAYFISGAKHLANAQTYPFHLSLDQKEQTIESSTVLVGLTNSIGGFETLLPEAQVDDGKLHLVYLKDQSLWDAVKAVPDL 238
Cdd:PRK13337 159 LAYYLKGIEMLPSLKATDVRIEYDGKLFQGEIMLFLLGLTNSVGGFEKLAPDASLDDGYFDLIIVKKANLAELIHIATLA 238
|
250 260 270 280 290 300
....*....|....*....|....*....|....*....|....*....|....*....|
gi 498399969 239 LKGVDQSTDNLVYLtfKEGTISLENQEELTTNVDGDEGAALPITLEILPKHLTVYCGEEQ 298
Cdd:PRK13337 239 LRGEHIKHPKVIYT--KANRIKVSSFDKMQLNLDGEYGGKLPAEFENLYRHIEVFVPKDQ 296
|
|
| TIGR00147 |
TIGR00147 |
lipid kinase, YegS/Rv2252/BmrU family; The E. coli member of this family, YegS has been ... |
1-292 |
2.14e-63 |
|
lipid kinase, YegS/Rv2252/BmrU family; The E. coli member of this family, YegS has been purified and shown to have phosphatidylglycerol kinase activity. The member from M. tuberculosis, Rv2252, has diacylglycerol kinase activity. BmrU from B. subtilis is in an operon with multidrug efflux transporter Bmr, but is uncharacterized. [Unknown function, Enzymes of unknown specificity]
Pssm-ID: 161732 [Multi-domain] Cd Length: 293 Bit Score: 201.96 E-value: 2.14e-63
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 498399969 1 MKKAVLIVNPSSGGEKAKEFETLAEEKLKQLFDEVVVKQTEKGGDAEQFAREAAESHFDSVFVMGGDGTVNEGISGLAEQ 80
Cdd:TIGR00147 1 MAEAPAILNPTAGKSNDNKPLREVIMLLREEGMEIHVRVTWEKGDAARYVEEARKFGVDTVIAGGGDGTINEVVNALIQL 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 498399969 81 AYRPKFGFFPLGTVNDLARALNLPMDPEEAIQQLDLEKTSALDVGKINDDY-FMNVVAIGTIPESINDVDVEQKTKLGKL 159
Cdd:TIGR00147 81 DDIPALGILPLGTANDFARSLGIPEDLDKAAKLVIAGDARAIDMGQVNKQYcFINMAGGGFGTEITTETPEKLKAALGSL 160
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 498399969 160 AYFISGAKHLANAQTYPFHLSLDQKEQTIESSTVLVGLTNSIGGFETLLPEAQVDDGKLHLVYLKDQSLWDAVKAVPDLL 239
Cdd:TIGR00147 161 SYILSGLMRMDTLQPFRCEIRGEGEHWQGEAVVFLVGNGRQAGGGQKLAPDASINDGLLDLRIFTNDNLLPALVLTLMSD 240
|
250 260 270 280 290
....*....|....*....|....*....|....*....|....*....|...
gi 498399969 240 KGVDQSTDNLVYltFKEGTISLENQEELTTNVDGDEGAALPITLEILPKHLTV 292
Cdd:TIGR00147 241 EGKHTDNPNIIY--GKASRIDIQTPHKITFNLDGEPLGGTPFHIEILPAHLRC 291
|
|
| DAGK_cat |
pfam00781 |
Diacylglycerol kinase catalytic domain; Diacylglycerol (DAG) is a second messenger that acts ... |
3-127 |
8.17e-48 |
|
Diacylglycerol kinase catalytic domain; Diacylglycerol (DAG) is a second messenger that acts as a protein kinase C activator. The catalytic domain is assumed from the finding of bacterial homologs. YegS is the Escherichia coli protein in this family whose crystal structure reveals an active site in the inter-domain cleft formed by four conserved sequence motifs, revealing a novel metal-binding site. The residues of this site are conserved across the family.
Pssm-ID: 425868 [Multi-domain] Cd Length: 125 Bit Score: 156.21 E-value: 8.17e-48
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 498399969 3 KAVLIVNPSSGGEKAKEFETLAEEKLKQLFDEVVVKQTEKGGDAEQFAREAAESHFDSVFVMGGDGTVNEGISGLAEQAY 82
Cdd:pfam00781 1 KLLVIVNPKSGGGKGKKLLRKVRPLLNKAGVEVELVLTEGPGDALELAREAAEDGYDRIVVAGGDGTVNEVLNGLAGLAT 80
|
90 100 110 120
....*....|....*....|....*....|....*....|....*
gi 498399969 83 RPKFGFFPLGTVNDLARALNLPMDPEEAIQQLDLEKTSALDVGKI 127
Cdd:pfam00781 81 RPPLGIIPLGTGNDFARALGIPGDPEEALEAILKGQTRPVDVGKV 125
|
|
| DAGKc |
smart00046 |
Diacylglycerol kinase catalytic domain (presumed); Diacylglycerol (DAG) is a second messenger ... |
5-108 |
2.85e-13 |
|
Diacylglycerol kinase catalytic domain (presumed); Diacylglycerol (DAG) is a second messenger that acts as a protein kinase C activator. DAG can be produced from the hydrolysis of phosphatidylinositol 4,5-bisphosphate (PIP2) by a phosphoinositide-specific phospholipase C and by the degradation of phosphatidylcholine (PC) by a phospholipase C or the concerted actions of phospholipase D and phosphatidate phosphohydrolase. This domain is presumed to be the catalytic domain. Bacterial homologues areknown.
Pssm-ID: 214487 [Multi-domain] Cd Length: 124 Bit Score: 65.40 E-value: 2.85e-13
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 498399969 5 VLIVNPSSGGEKAKEFEtlaeEKLKQLFDEVVVKQTEKGGDAEQFAREAAESHFDSVFVMGGDGTVNEGISGLAE---QA 81
Cdd:smart00046 1 LVFVNPKSGGGKGEKLL----RKFRLLLNPRQVFDLTKKGPAVALVIFRDVPDFNRVLVCGGDGTVGWVLNALDKrelPL 76
|
90 100
....*....|....*....|....*..
gi 498399969 82 YRPKFGFFPLGTVNDLARALNLPMDPE 108
Cdd:smart00046 77 PEPPVAVLPLGTGNDLARSLGWGGGYD 103
|
|
|
|
Name |
Accession |
Description |
Interval |
E-value |
| LCB5 |
COG1597 |
Phosphatidylglycerol kinase, diacylglycerol kinase family [Lipid transport and metabolism, ... |
1-297 |
1.46e-99 |
|
Phosphatidylglycerol kinase, diacylglycerol kinase family [Lipid transport and metabolism, General function prediction only];
Pssm-ID: 441205 [Multi-domain] Cd Length: 295 Bit Score: 294.07 E-value: 1.46e-99
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 498399969 1 MKKAVLIVNPSSGGEKAKEFETLAEEKLKQLFDEVVVKQTEKGGDAEQFAREAAESHFDSVFVMGGDGTVNEGISGLAEQ 80
Cdd:COG1597 2 MMRALLIVNPASGRGRAARLLERLVAALRAAGLEVEVLETESPGDATELAREAAAEGADLVVAAGGDGTVNEVANGLAGT 81
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 498399969 81 ayRPKFGFFPLGTVNDLARALNLPMDPEEAIQQLDLEKTSALDVGKINDDYFMNVVAIGTIPESINDVDVEQKTKLGKLA 160
Cdd:COG1597 82 --GPPLGILPLGTGNDFARALGIPLDPEAALEALLTGRTRRIDLGRVNGRYFLNVAGIGFDAEVVERANRALKRRLGKLA 159
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 498399969 161 YFISGAKHLANAQTYPFHLSLDQKEQTIESSTVLVGLTNSIGGFETLLPEAQVDDGKLHLVYLKDQSLWDAVKAVPDLLK 240
Cdd:COG1597 160 YVLAALRALLRYRPFRLRIELDGEEIEGEALLVAVGNGPYYGGGLRLAPDASLDDGLLDVVVVRPLSRLRLLRLLPRLLR 239
|
250 260 270 280 290
....*....|....*....|....*....|....*....|....*....|....*...
gi 498399969 241 GVDQSTDNLVYLTFKEgtISLENQEELTTNVDGDE-GAALPITLEILPKHLTVYCGEE 297
Cdd:COG1597 240 GRHLRHPGVRYFRARE--VEIESDRPLPVQLDGEPlGLATPLEFEVLPGALRVLVPAD 295
|
|
| PRK13337 |
PRK13337 |
putative lipid kinase; Reviewed |
1-298 |
6.16e-69 |
|
putative lipid kinase; Reviewed
Pssm-ID: 183982 [Multi-domain] Cd Length: 304 Bit Score: 216.45 E-value: 6.16e-69
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 498399969 1 MKKAVLIVNPSSGGEKAKEfeTLAE--EKLKQLFDEVVVKQTEKGGDAEQFAREAAESHFDSVFVMGGDGTVNEGISGLA 78
Cdd:PRK13337 1 MKRARIIYNPTSGRELFKK--NLPDvlQKLEQAGYETSAHATTGPGDATLAAERAVERKFDLVIAAGGDGTLNEVVNGIA 78
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 498399969 79 EQAYRPKFGFFPLGTVNDLARALNLPMDPEEAIQQLDLEKTSALDVGKINDDYFMNVVAIGTIPESINDVDVEQKTKLGK 158
Cdd:PRK13337 79 EKENRPKLGIIPVGTTNDFARALHVPRDIEKAADVIIEGHTVPVDIGKANNRYFINIAGGGRLTELTYEVPSKLKTMLGQ 158
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 498399969 159 LAYFISGAKHLANAQTYPFHLSLDQKEQTIESSTVLVGLTNSIGGFETLLPEAQVDDGKLHLVYLKDQSLWDAVKAVPDL 238
Cdd:PRK13337 159 LAYYLKGIEMLPSLKATDVRIEYDGKLFQGEIMLFLLGLTNSVGGFEKLAPDASLDDGYFDLIIVKKANLAELIHIATLA 238
|
250 260 270 280 290 300
....*....|....*....|....*....|....*....|....*....|....*....|
gi 498399969 239 LKGVDQSTDNLVYLtfKEGTISLENQEELTTNVDGDEGAALPITLEILPKHLTVYCGEEQ 298
Cdd:PRK13337 239 LRGEHIKHPKVIYT--KANRIKVSSFDKMQLNLDGEYGGKLPAEFENLYRHIEVFVPKDQ 296
|
|
| PRK13055 |
PRK13055 |
putative lipid kinase; Reviewed |
1-297 |
8.88e-68 |
|
putative lipid kinase; Reviewed
Pssm-ID: 237282 [Multi-domain] Cd Length: 334 Bit Score: 214.47 E-value: 8.88e-68
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 498399969 1 MKKAVLIVNPSSGGEKAKEFETLAEEKLKQLFDEVVVKQTEKGGDAEQF-AREAAESHFDSVFVMGGDGTVNEGISGLAE 79
Cdd:PRK13055 2 QKRARLIYNPTSGQEIMKKNVADILDILEQAGYETSAFQTTPEPNSAKNeAKRAAEAGFDLIIAAGGDGTINEVVNGIAP 81
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 498399969 80 QAYRPKFGFFPLGTVNDLARALNLPM-DPEEAIQQLDLEKTSALDVGKINDD-YFMNVVAIGTIPESINDVDVEQKTKLG 157
Cdd:PRK13055 82 LEKRPKMAIIPAGTTNDYARALKIPRdNPVEAAKVILKNQTIKMDIGRANEDkYFINIAAGGSLTELTYSVPSQLKSMFG 161
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 498399969 158 KLAYFISGAKHLANAQTYPFHLSLDQKEQTIESSTVLVGLTNSIGGFETLLPEAQVDDGKLHLVYLKDQSLWDAVKAVPD 237
Cdd:PRK13055 162 YLAYLAKGAELLPRVSPVPVRITYDEGVFEGKISMFFLALTNSVGGFEQIVPDAKLDDGKFTLIIVKTANLFELLHLMAL 241
|
250 260 270 280 290 300
....*....|....*....|....*....|....*....|....*....|....*....|.
gi 498399969 238 LLKGVDQSTD-NLVYLTFKEGTISLENQEELTTNVDGDEGAALPITLEILPKHLTVYCGEE 297
Cdd:PRK13055 242 ILNGGKHIDDpRVIYIKTSKLTIEPLGDDRLMVNLDGEYGGDAPMTFENLKQHIEFFANTD 302
|
|
| TIGR00147 |
TIGR00147 |
lipid kinase, YegS/Rv2252/BmrU family; The E. coli member of this family, YegS has been ... |
1-292 |
2.14e-63 |
|
lipid kinase, YegS/Rv2252/BmrU family; The E. coli member of this family, YegS has been purified and shown to have phosphatidylglycerol kinase activity. The member from M. tuberculosis, Rv2252, has diacylglycerol kinase activity. BmrU from B. subtilis is in an operon with multidrug efflux transporter Bmr, but is uncharacterized. [Unknown function, Enzymes of unknown specificity]
Pssm-ID: 161732 [Multi-domain] Cd Length: 293 Bit Score: 201.96 E-value: 2.14e-63
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 498399969 1 MKKAVLIVNPSSGGEKAKEFETLAEEKLKQLFDEVVVKQTEKGGDAEQFAREAAESHFDSVFVMGGDGTVNEGISGLAEQ 80
Cdd:TIGR00147 1 MAEAPAILNPTAGKSNDNKPLREVIMLLREEGMEIHVRVTWEKGDAARYVEEARKFGVDTVIAGGGDGTINEVVNALIQL 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 498399969 81 AYRPKFGFFPLGTVNDLARALNLPMDPEEAIQQLDLEKTSALDVGKINDDY-FMNVVAIGTIPESINDVDVEQKTKLGKL 159
Cdd:TIGR00147 81 DDIPALGILPLGTANDFARSLGIPEDLDKAAKLVIAGDARAIDMGQVNKQYcFINMAGGGFGTEITTETPEKLKAALGSL 160
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 498399969 160 AYFISGAKHLANAQTYPFHLSLDQKEQTIESSTVLVGLTNSIGGFETLLPEAQVDDGKLHLVYLKDQSLWDAVKAVPDLL 239
Cdd:TIGR00147 161 SYILSGLMRMDTLQPFRCEIRGEGEHWQGEAVVFLVGNGRQAGGGQKLAPDASINDGLLDLRIFTNDNLLPALVLTLMSD 240
|
250 260 270 280 290
....*....|....*....|....*....|....*....|....*....|...
gi 498399969 240 KGVDQSTDNLVYltFKEGTISLENQEELTTNVDGDEGAALPITLEILPKHLTV 292
Cdd:TIGR00147 241 EGKHTDNPNIIY--GKASRIDIQTPHKITFNLDGEPLGGTPFHIEILPAHLRC 291
|
|
| DAGK_cat |
pfam00781 |
Diacylglycerol kinase catalytic domain; Diacylglycerol (DAG) is a second messenger that acts ... |
3-127 |
8.17e-48 |
|
Diacylglycerol kinase catalytic domain; Diacylglycerol (DAG) is a second messenger that acts as a protein kinase C activator. The catalytic domain is assumed from the finding of bacterial homologs. YegS is the Escherichia coli protein in this family whose crystal structure reveals an active site in the inter-domain cleft formed by four conserved sequence motifs, revealing a novel metal-binding site. The residues of this site are conserved across the family.
Pssm-ID: 425868 [Multi-domain] Cd Length: 125 Bit Score: 156.21 E-value: 8.17e-48
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 498399969 3 KAVLIVNPSSGGEKAKEFETLAEEKLKQLFDEVVVKQTEKGGDAEQFAREAAESHFDSVFVMGGDGTVNEGISGLAEQAY 82
Cdd:pfam00781 1 KLLVIVNPKSGGGKGKKLLRKVRPLLNKAGVEVELVLTEGPGDALELAREAAEDGYDRIVVAGGDGTVNEVLNGLAGLAT 80
|
90 100 110 120
....*....|....*....|....*....|....*....|....*
gi 498399969 83 RPKFGFFPLGTVNDLARALNLPMDPEEAIQQLDLEKTSALDVGKI 127
Cdd:pfam00781 81 RPPLGIIPLGTGNDFARALGIPGDPEEALEAILKGQTRPVDVGKV 125
|
|
| PRK13057 |
PRK13057 |
lipid kinase; |
6-293 |
1.42e-38 |
|
lipid kinase;
Pssm-ID: 183857 [Multi-domain] Cd Length: 287 Bit Score: 137.36 E-value: 1.42e-38
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 498399969 6 LIVNPSSggEKAKEFETLAEEKLKQLFDEVVVKQTEKGGDAEQFAREAAEShFDSVFVMGGDGTVNEGISGLAEQayRPK 85
Cdd:PRK13057 2 LLVNRHA--RSGRAALAAARAALEAAGLELVEPPAEDPDDLSEVIEAYADG-VDLVIVGGGDGTLNAAAPALVET--GLP 76
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 498399969 86 FGFFPLGTVNDLARALNLPMDPEEAIQQLDLEKTSALDVGKINDDYFMNVVAIGTIPESINDVDVEQKTKLGKLAYFISG 165
Cdd:PRK13057 77 LGILPLGTANDLARTLGIPLDLEAAARVIATGQVRRIDLGWVNGHYFFNVASLGLSAELARRLTKELKRRWGTLGYAIAA 156
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 498399969 166 AKHLANAQtyPFHLSLDQKEQTIESSTVLVGLTNS--IGGFETLLPEAQVDDGKLHLVYLKDQSLWDAVKAVPDLLKGVD 243
Cdd:PRK13057 157 LRVLRRSR--PFTAEIEHDGRTERVKTLQVAVGNGryYGGGMTVAHDATIDDGRLDLYSLEVAHWWRLLALLPALRRGRH 234
|
250 260 270 280 290
....*....|....*....|....*....|....*....|....*....|
gi 498399969 244 QSTDNLvyLTFKEGTISLENQEELTTNVDGDEGAALPITLEILPKHLTVY 293
Cdd:PRK13057 235 GEWPDV--RAFRTTELELRTRKPRPINTDGELTTYTPAHFRVLPKALRVL 282
|
|
| PRK13059 |
PRK13059 |
putative lipid kinase; Reviewed |
1-292 |
3.80e-38 |
|
putative lipid kinase; Reviewed
Pssm-ID: 183858 Cd Length: 295 Bit Score: 136.32 E-value: 3.80e-38
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 498399969 1 MKKAVLIVNPSSGGEK-AKEFETLAEEKLKQLFDEVVVKQTEKGGDAEQFarEAAESHFDSVFVMGGDGTVNEGISGLAE 79
Cdd:PRK13059 1 MKKVKFIYNPYSGENAiISELDKVIRIHQEKGYLVVPYRISLEYDLKNAF--KDIDESYKYILIAGGDGTVDNVVNAMKK 78
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 498399969 80 QAYRPKFGFFPLGTVNDLARALNLPMDPEEAIQQLDLEKTSALDVGKINDDYFMNVVAIGTIPESINDVDVEQKTKLGKL 159
Cdd:PRK13059 79 LNIDLPIGILPVGTANDFAKFLGMPTDIGEACEQILKSKPKKVDLGKINDKYFINVASTGLFTDVSQKTDVNLKNTIGKL 158
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 498399969 160 AYFISGAKHLANAQtyPFHLSLDQKEQTIESSTVLVGLTN--SIGGFEtLLPEAQVDDGKLHLVYLKDQSLWDAVKAVPD 237
Cdd:PRK13059 159 AYYLKGLEELPNFR--KLKVKVTSEEVNFDGDMYLMLVFNgqTAGNFN-LAYKAEVDDGLLDVIIIKACPIIDLIPLFIK 235
|
250 260 270 280 290
....*....|....*....|....*....|....*....|....*....|....*
gi 498399969 238 LLKGVDQSTDNLVyLTFKEGTISLENQEELTTNVDGDEGAALPITLEILPKHLTV 292
Cdd:PRK13059 236 VLKGEHLEDVNGL-IYFKTDKLEIESNEEIVTDIDGERGPDFPLNIECIKGGLKV 289
|
|
| PRK13054 |
PRK13054 |
lipid kinase; Reviewed |
1-290 |
2.38e-34 |
|
lipid kinase; Reviewed
Pssm-ID: 237281 [Multi-domain] Cd Length: 300 Bit Score: 126.53 E-value: 2.38e-34
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 498399969 1 MKKAVLIVN-PSSGGEKAKEfetlAEEKLKQLFDEVVVKQTEKGGDAEQFAREAAESHFDSVFVMGGDGTVNEGISGLA- 78
Cdd:PRK13054 3 FPKSLLILNgKSAGNEELRE----AVGLLREEGHTLHVRVTWEKGDAARYVEEALALGVATVIAGGGDGTINEVATALAq 78
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 498399969 79 -EQAYRPKFGFFPLGTVNDLARALNLPMDPEEAIqQLDLE-KTSALDVGKINDD-YFMNVVAIGTIPESINDVDVEQKTK 155
Cdd:PRK13054 79 lEGDARPALGILPLGTANDFATAAGIPLEPDKAL-KLAIEgRAQPIDLARVNDRtYFINMATGGFGTRVTTETPEKLKAA 157
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 498399969 156 LGKLAYFISGAKHLANAQTYP-------FHLSLDqkeqtiessTVLVGLTNS--IGGFETLLPEAQVDDGKLHLVYLKdq 226
Cdd:PRK13054 158 LGGVAYLIHGLMRMDTLKPDRceirgpdFHWQGD---------ALVIGIGNGrqAGGGQQLCPEALINDGLLDLRILP-- 226
|
250 260 270 280 290 300
....*....|....*....|....*....|....*....|....*....|....*....|....
gi 498399969 227 SLWDAVKAVPDLLKGVDQSTDNLVYLTFKEGTISLENqeELTTNVDGDEGAALPITLEILPKHL 290
Cdd:PRK13054 227 APQELLPTLLSTLTGGSEDNPNIIRARLPWLEIQAPH--ELTFNLDGEPLSGRHFRIEVLPAAL 288
|
|
| PRK12361 |
PRK12361 |
hypothetical protein; Provisional |
2-300 |
1.38e-33 |
|
hypothetical protein; Provisional
Pssm-ID: 183473 [Multi-domain] Cd Length: 547 Bit Score: 128.58 E-value: 1.38e-33
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 498399969 2 KKAVLIVNPSSGGEKAKEFETLAEEKLKQLFDeVVVKQTEKGGDAEQFAREAAESHFDSVFVMGGDGTVNEGISGLAEQa 81
Cdd:PRK12361 243 KRAWLIANPVSGGGKWQEYGEQIQRELKAYFD-LTVKLTTPEISAEALAKQARKAGADIVIACGGDGTVTEVASELVNT- 320
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 498399969 82 yRPKFGFFPLGTVNDLARAL----NLPMDPEEAIQQLDLEKTSALDVGKINDDYFMNVVAIGTIPESINDVDVEQKTKLG 157
Cdd:PRK12361 321 -DITLGIIPLGTANALSHALfglgSKLIPVEQACDNIIQGHTQRIDTARCNDRLMLLLVGIGFEQKMIESADRERKNALG 399
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 498399969 158 KLAYfISGA-KHLANAQTYPFHLSLDQKE-QTIESSTVLVGltnSIGGFETLLP----EAQVDDGKLHLVYL-KDQSLWD 230
Cdd:PRK12361 400 QLAY-LDGLwRAVNENETLTLTVTLDDAEpQTISTHSLVVA---NAAPFTSLLAqgggEPNMTDGLLDITWLdSGGEPGE 475
|
250 260 270 280 290 300 310
....*....|....*....|....*....|....*....|....*....|....*....|....*....|..
gi 498399969 231 AVKAVPDL-LKGV-DQSTDNLVYLTfKEGTISLENQEELTTNVDGDEGAALPITLEILPKHLTVYCGEEQTK 300
Cdd:PRK12361 476 QLLSLAELaLSGLgKEPEANKVHHA-HAKKVTISSQKPIKYVIDGELFEDEDLTIEVQPASLKVFVPYQEIN 546
|
|
| PRK00861 |
PRK00861 |
putative lipid kinase; Reviewed |
1-293 |
6.22e-32 |
|
putative lipid kinase; Reviewed
Pssm-ID: 234850 [Multi-domain] Cd Length: 300 Bit Score: 120.11 E-value: 6.22e-32
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 498399969 1 MKKAVLIVNPSSGGEKAKEFETLAEEKLKQLFDEVVVKQTEKGGdAEQFAREAAESHFDSVFVMGGDGTVNEGISGLAE- 79
Cdd:PRK00861 2 TRSACLIFNPVAGQGNPEVDLALIRAILEPEMDLDIYLTTPEIG-ADQLAQEAIERGAELIIASGGDGTLSAVAGALIGt 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 498399969 80 QAYrpkFGFFPLGTVNDLARALNLPMDPEEAIQQLDLEKTSALDVGKINDDYFMNVVAIGTIPESINDVDVEQKTKLGKL 159
Cdd:PRK00861 81 DIP---LGIIPRGTANAFAAALGIPDTIEEACRTILQGKTRRVDVAYCNGQPMILLAGIGFEAETVEEADREAKNRFGIL 157
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 498399969 160 AYFISGAKHLANAQtyPFHLSLDQKEQTIESSTVLVGLTN-----SI--GGFETLLPeaqvDDGKLHLVYLKDQSLWDAV 232
Cdd:PRK00861 158 AYILSGLQQLRELE--SFEVEIETEDQIITTNAVAVTVANaapptSVlaQGPGAVIP----DDGLLDVTIVAPKNLAEAV 231
|
250 260 270 280 290 300
....*....|....*....|....*....|....*....|....*....|....*....|....*
gi 498399969 233 KAVPDLLKGVDQST----DNLVYLTFKEGTISLENQEELTtnVDGDEGAALPITLEILPKHLTVY 293
Cdd:PRK00861 232 AASYHLLQTALQGNpaerDDIGYLRAKQVKITTDPPQKVV--IDGEVVGTTPIEIECLPRSLKVF 294
|
|
| PRK11914 |
PRK11914 |
diacylglycerol kinase; Reviewed |
1-292 |
1.19e-21 |
|
diacylglycerol kinase; Reviewed
Pssm-ID: 237021 [Multi-domain] Cd Length: 306 Bit Score: 92.54 E-value: 1.19e-21
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 498399969 1 MKKAVLIVNPSSGGEKAKEFETLAEEKLKQLFDEVVVKQTEKGGDAEQFAREAAESHFDSVFVMGGDGTVNEGISGLAEQ 80
Cdd:PRK11914 8 IGKVTVLTNPLSGHGAAPHAAERAIARLHHRGVDVVEIVGTDAHDARHLVAAALAKGTDALVVVGGDGVISNALQVLAGT 87
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 498399969 81 AYrpKFGFFPLGTVNDLARALNLPM-DPEEAIQQLDLEKTSALDVGKINDD-----YFMNVVAIGtIPESINDVDVEQKT 154
Cdd:PRK11914 88 DI--PLGIIPAGTGNDHAREFGIPTgDPEAAADVIVDGWTETVDLGRIQDDdgivkWFGTVAATG-FDSLVTDRANRMRW 164
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 498399969 155 KLGKLAYFISGAKHLANAQTYPFHLSLDQKEQ-TIESSTVLVGLTNSIGGFETLLPEAQVDDGKLHLVYLKDQSLWDAVK 233
Cdd:PRK11914 165 PHGRMRYNLAMLAELSKLRPLPFRLVLDGTEEiVTDLTLAAFGNTRSYGGGMLICPNADHTDGLLDITMVQSASRTRLLR 244
|
250 260 270 280 290
....*....|....*....|....*....|....*....|....*....|....*....
gi 498399969 234 AVPDLLKGVDQSTDNLVylTFKEGTISLENqEELTTNVDGDEGAALPITLEILPKHLTV 292
Cdd:PRK11914 245 LFPTVFKGTHVELDEVS--TARAKTVHVEC-PGINAYADGDFACPLPAEISAVPGALQI 300
|
|
| DAGKc |
smart00046 |
Diacylglycerol kinase catalytic domain (presumed); Diacylglycerol (DAG) is a second messenger ... |
5-108 |
2.85e-13 |
|
Diacylglycerol kinase catalytic domain (presumed); Diacylglycerol (DAG) is a second messenger that acts as a protein kinase C activator. DAG can be produced from the hydrolysis of phosphatidylinositol 4,5-bisphosphate (PIP2) by a phosphoinositide-specific phospholipase C and by the degradation of phosphatidylcholine (PC) by a phospholipase C or the concerted actions of phospholipase D and phosphatidate phosphohydrolase. This domain is presumed to be the catalytic domain. Bacterial homologues areknown.
Pssm-ID: 214487 [Multi-domain] Cd Length: 124 Bit Score: 65.40 E-value: 2.85e-13
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 498399969 5 VLIVNPSSGGEKAKEFEtlaeEKLKQLFDEVVVKQTEKGGDAEQFAREAAESHFDSVFVMGGDGTVNEGISGLAE---QA 81
Cdd:smart00046 1 LVFVNPKSGGGKGEKLL----RKFRLLLNPRQVFDLTKKGPAVALVIFRDVPDFNRVLVCGGDGTVGWVLNALDKrelPL 76
|
90 100
....*....|....*....|....*..
gi 498399969 82 YRPKFGFFPLGTVNDLARALNLPMDPE 108
Cdd:smart00046 77 PEPPVAVLPLGTGNDLARSLGWGGGYD 103
|
|
| YegS_C |
pfam19279 |
YegS C-terminal NAD kinase beta sandwich-like domain; This entry represents the C-terminal ... |
156-294 |
9.40e-08 |
|
YegS C-terminal NAD kinase beta sandwich-like domain; This entry represents the C-terminal domain found in the YegS protein. It is related to the beta sandwich domain of NAD kinases. The structure of YegS reveals a two-domain protein with the active site crevice found between the two domains. The C-terminal domain contains 13 beta-strands and two alpha-helices. The likely substrate for YegS is phosphatidylglycerol.
Pssm-ID: 437111 Cd Length: 158 Bit Score: 50.66 E-value: 9.40e-08
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 498399969 156 LGKLAYFISGAKHLANAQTYPFHLSLDQKEQTIESSTVLVGLTNSIGGFETLLPEAQVDDGKLHLVYLKDQSLWDAVKAV 235
Cdd:pfam19279 22 PGALSYPAAALRALATFRPLRYRVTVDGEVREFSAALVAVANSGYYGGGMRIAPDARVDDGLLDVVVIEAASRRTLLRLL 101
|
90 100 110 120 130
....*....|....*....|....*....|....*....|....*....|....*....
gi 498399969 236 PDLLKGVDQSTDNLVYLTFKEgtISLENQEELTTNVDGDEGAALPITLEILPKHLTVYC 294
Cdd:pfam19279 102 PKVYDGRHVRLPQVEVLRGRE--VRIEADRPLPAGADGEVLGPLPVRVEVLPGALRVLA 158
|
|
| PLN02958 |
PLN02958 |
diacylglycerol kinase/D-erythro-sphingosine kinase |
2-151 |
9.97e-04 |
|
diacylglycerol kinase/D-erythro-sphingosine kinase
Pssm-ID: 215517 [Multi-domain] Cd Length: 481 Bit Score: 40.61 E-value: 9.97e-04
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 498399969 2 KKAVLIVNPSSGGEKA-KEFETLAEEKLKQLFDEVVVKQTEKGGDAEQFAREAAESHFDSVFVMGGDGTVNEGISGLAEQ 80
Cdd:PLN02958 112 KRLLVFVNPFGGKKSAsKIFFDVVKPLLEDADIQLTIQETKYQLHAKEVVRTMDLSKYDGIVCVSGDGILVEVVNGLLER 191
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 498399969 81 -----AYRPKFGFFPLGTVNDLARAL----NLPMDPEEAIQQLDLEKTSALDVGKI--NDDYFMNVV--AIGTIPesinD 147
Cdd:PLN02958 192 edwktAIKLPIGMVPAGTGNGMAKSLldsvGEPCSATNAVLAIIRGHKCSLDVATIlqGETKFFSVLmlAWGLVA----D 267
|
....
gi 498399969 148 VDVE 151
Cdd:PLN02958 268 IDIE 271
|
|
| NadK |
COG0061 |
NAD kinase [Coenzyme transport and metabolism]; |
1-70 |
4.06e-03 |
|
NAD kinase [Coenzyme transport and metabolism];
Pssm-ID: 439831 [Multi-domain] Cd Length: 279 Bit Score: 38.19 E-value: 4.06e-03
10 20 30 40 50 60 70
....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 498399969 1 MKKAVLIVNPSSggEKAKEFETLAEEKLKQLFDEVVVkqtEKGGDAEQFAREAAESHFDSVFVMGGDGTV 70
Cdd:COG0061 1 MKRIAIVAKPGK--PEALEAAEELAELLEERGIEVVL---DEDTAVPGVPLEELGEEADLVIVLGGDGTL 65
|
|
|